Skip to content
June 11, 2026
Facebook
Instagram
Youtube
Linkedin
GET LISTED
BANKING & FINANCE
TECHNOLOGY
CORPORATE
LIFESTYLE
NEWS
BLOG
EVENTS
Events 2026
AWARDS
GALLERY
MAGAZINE
BANKING & FINANCE
TECHNOLOGY
CORPORATE
LIFESTYLE
NEWS
BLOG
EVENTS
Events 2026
AWARDS
GALLERY
MAGAZINE
Home
Banking and Finance
Corporate
News
Technology
Blog
Lifestyle
Events
Events 2026
Awards
Gallery
Nomination
Magazine
Get Listed
About us
Get In Touch
Sitemap
YOU ARE AT:
Home
ยป
biopharmaceutical
Banking and Finance
CE-Ventures announces its final close of the USD 26mln Series A funding round
07 July, 2023
Corporate
Trevi Therapeutics onboards David Clark as CMO
15 November, 2022
Corporate
Angel Pharma's IND application for mupadolimab approved by CDE
27 September, 2022
BROWSING:
biopharmaceutical
Banking and Finance
CE-Ventures announces its final close of the USD 26mln Series A funding round
July 7, 2023
CE-Ventures, the corporate venture capital platform of Crescent Enterprises, a leading global, diversified...
Read More
Corporate
Trevi Therapeutics onboards David Clark as CMO
November 15, 2022
Trevi Therapeutics, Inc. a clinical-stage biopharmaceutical company developing the investigational therapy...
Read More
Corporate
Angel Pharma's IND application for mupadolimab approved by CDE
September 27, 2022
Angel Pharmaceuticals Ltd. (“Angel Pharma”), a clinical-stage biopharmaceutical company,ย recently...
Read More
Corporate
Genexineโs Therapeutic DNA Vaccine shows significant development
September 12, 2022
Genexine , a publicly traded, clinical-stage Korean biopharmaceutical company committed to the discovery...
Read More
Welcome to Himel : Products of today, ready for tomorrow
LATEST POSTS
BIBF introduces integrated AI-driven hiring and assessment solutions in partnership with Sirati
June 11, 2026
The Lighting Innovation + Modern Buildings Summit will take place on 23 June 2026 in Muscat, Oman
June 10, 2026
Wio Invest Names iShares by BlackRock for Tax-Efficient UCITS ETFs
June 10, 2026
Kingston Technology Showcases Advanced Memory for Next-Gen Innovation
June 10, 2026